caspofungine
J - Antiinfectives For Systemic Use -> J02 - Antimycotics For Systemic Use -> J02A - Antimycotics For Systemic Use -> J02AX - Other Antimycotics For Systemic Use -> J02AX04 - Caspofungin
Administration category:
Free
Medicine group:
antifungal
Brand name:
Cancidas
Standard dosages
| Weight | ROA | Load | Dosage |
|---|---|---|---|
| < 80 kg | |||
|
ROA: iv |
Load: 70mg |
Dosage: 50mg 1 dd |
|
| ≥ 80 kg | |||
|
ROA: iv |
Load: 70mg |
Dosage: 70mg 1 dd |
|
Kidney function
Renal elimination:
2%
Dosage:
independent on kidney function
Interactions
| Interaction with (ATC): | Expected effect: |
|---|---|
|
Interaction with (ATC): L04AD01 - Ciclosporin |
Expected effect: verhoging plasmaconcentratie caspofungin |
|
Interaction with (ATC): L04AD02 - Tacrolimus |
Expected effect: verlaging dalconcentratie tacrolimus |
|
Interaction with (ATC): J04AB02 - Rifampicin |
Expected effect: verlaging plasmaconcentratie caspofungin |
|
Interaction with (ATC): N03AB02 - Phenytoin |
Expected effect: verlaging plasmaconcentratie caspofungin |
|
Interaction with (ATC): N03AF01 - Carbamazepine |
Expected effect: verlaging plasmaconcentratie caspofungin |
|
Interaction with (ATC): H02AB02 - Dexamethasone |
Expected effect: verlaging plasmaconcentratie caspofungin |
|
Interaction with (ATC): J05AG01 - Nevirapine |
Expected effect: verlaging plasmaconcentratie caspofungin |
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-2091.1
Updated: 06/16/2019 - 20:05
Status: Published